Dr. Krasner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street Yaw 9
Gillette Center for Womens Cancer
Boston, MA 02114Phone+1 617-724-3200Fax+1 617-726-2894
Education & Training
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1995 - 1998
- University of Vermont College of MedicineClass of 1995
Certifications & Licensure
- MA State Medical License 2000 - 2026
- ME State Medical License 2022 - 2026
- RI State Medical License 2022 - 2026
- CT State Medical License 2022 - 2025
Clinical Trials
- Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer Start of enrollment: 2003 Oct 01
- Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin Start of enrollment: 2004 Oct 01
- Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsFeasibility and acceptability of a nurse-led telehealth intervention (BOLSTER) to support patients with peritoneal carcinomatosis and their caregivers: A pilot randomi...Rachel A Pozzar, Andrea C Enzinger, Catherine Howard, Anna Tavormina, Ursula A Matulonis
Gynecologic Oncology. 2024-09-01 - Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer.Panagiotis A Konstantinopoulos, Niya Xiong, Carolyn Krasner, Joyce F Liu, Hannah Sawyer
Gynecologic Oncology Reports. 2024-04-01 - 3 citationsKidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors.Shruti Gupta, Paul E Hanna, Tianqi Ouyang, Karla Sofia Yamada, Rani Sawtell
Journal of the National Cancer Institute. 2023-07-06
Press Mentions
- Ovarian Cancer Patient Benefits from New ResearchSeptember 25th, 2020
- Cerulean Pharma - 13 January 2016 - PHARMACYJanuary 13th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: